The health secretary and his FDA chief, Marty Makary, can’t agree on how to proceed with vaccine safety studies.

Vinay Prasad and Tracy Beth Høeg mix skepticism with new ways to define risk in pursuing sweeping changes to vaccine policy at the FDA.

This year’s respiratory virus season comes with some unique challenges. Experts and providers say they’re worried about how ...

The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...

We know that parents just want to keep their kids safe, but part of the confusion comes from how fast information changes,” Adams said.

On August 22, 2025, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) suspended the biologics license for IXCHIQ, a live-attenuated chikungunya vaccine, ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

The Food and Drug Administration approved the next round of COVID-19 vaccines Wednesday, but imposed new restrictions on who's eligible to get them. The agency is limiting the updated shots to people ...

Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...

Every day, millions of patients and families do their best to make the right health care decisions for themselves and their loved ones. This cannot happen without the freedom to choose from a wide ...

The Infectious Diseases Society of America updates flu and RSV vaccine guidelines, emphasizing safety for immunocompromised patients during respiratory virus season. The Infectious Diseases Society of ...